Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult-type Diffuse Gliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01164189
What this trial is testing

Bevacizumab in Recurrent Grade II and III Glioma

Who this might be right for
Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 155
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT04923126
What this trial is testing

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Who this might be right for
Low-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma
St. Jude Children's Research Hospital 132
Testing effectiveness (Phase 2)Study completedNCT00003466
What this trial is testing

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 100
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Testing effectiveness (Phase 2)Study completedNCT00498927
What this trial is testing

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 47
Not applicableStudy completedNCT03739372
What this trial is testing

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

Who this might be right for
GliomaGlioma of BrainCancer+5 more
University of California, San Francisco 44
Testing effectiveness (Phase 2)Study completedNCT00499473
What this trial is testing

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Diffuse AstrocytomaAdult Giant Cell Glioblastoma+5 more
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)Study completedNCT00369785
What this trial is testing

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Who this might be right for
Brain TumorsMetastatic Disease
Wake Forest University Health Sciences 198
Testing effectiveness (Phase 2)Study completedNCT00112736
What this trial is testing

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+8 more
National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)UnknownNCT02233049
What this trial is testing

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Gustave Roussy, Cancer Campus, Grand Paris 250
Early research (Phase 1)Study completedNCT02186509
What this trial is testing

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+11 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 17
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT01024907
What this trial is testing

Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas

Who this might be right for
Adult Brain TumorAdult Brain Stem GliomaAdult Diffuse Astrocytoma+9 more
Abramson Cancer Center at Penn Medicine 23
Testing effectiveness (Phase 2)Looking for participantsNCT07680439
What this trial is testing

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Who this might be right for
Diffuse Intrinsic Pontine GliomaDIPGBrain Tumor+9 more
BrainChild Bio, Inc 75
Testing effectiveness (Phase 2)Ended earlyNCT02525692
What this trial is testing

Oral ONC201 in Adult Recurrent Glioblastoma

Who this might be right for
GlioblastomaDiffuse Midline GliomaH3 K27M Glioma+3 more
Jazz Pharmaceuticals 84
Early research (Phase 1)Looking for participantsNCT06860594
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Who this might be right for
Astrocytoma, IDH-Mutant, Grade 2Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Adult Diffuse Midline Glioma, H3 K27-Mutant+4 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Active Not RecruitingNCT03478462
What this trial is testing

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Who this might be right for
Pediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more
Cellectar Biosciences, Inc. 30
Early research (Phase 1)Looking for participantsNCT04732065
What this trial is testing

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Who this might be right for
Diffuse Midline Glioma (DMG)GlioblastomaRecurrent Ependymoma+5 more
Sabine Mueller, MD, PhD 208
Testing effectiveness (Phase 2)Study completedNCT01635283
What this trial is testing

Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Who this might be right for
Adult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+2 more
Jonsson Comprehensive Cancer Center 5
Next Page